PIOHOPE 15 10'S

About

Pioglitazone is an oral antidiabetic agent belonging to the thiazolidinedione class. It acts primarily by increasing insulin sensitivity in peripheral tissues and the liver, thereby improving glucose uptake and utilization. This mechanism involves activating peroxisome proliferator-activated receptor-gamma (PPAR-gamma) nuclear receptors, which regulate the transcription of several insulin-responsive genes involved in glucose and lipid metabolism. By enhancing the body's response to its own insulin, pioglitazone effectively lowers elevated blood glucose levels and reduces insulin resistance, a hallmark of type 2 diabetes mellitus. It also has beneficial effects on lipid profiles, often reducing triglycerides and increasing high-density lipoprotein (HDL) cholesterol, though it may increase low-density lipoprotein (LDL) cholesterol in some patients. Its therapeutic action helps in achieving better glycemic control and reducing HbA1c levels over time.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of insulin sensitivity.
• Reduction of elevated blood glucose levels.
• Adjunct to diet and exercise for glycemic control.

Directions For Use

Take orally once daily, with or without food, as directed by your physician.

Benefits

• Effectively lowers blood glucose levels.
• Improves insulin sensitivity in target tissues.
• Reduces HbA1c, indicating long-term glycemic control.
• May have beneficial effects on lipid profiles.
• Convenient once-daily dosing regimen.
• Helps manage the progression of type 2 diabetes.

Side Effects

• Weight gain
• Peripheral edema
• Upper respiratory tract infection
• Headache
• Sinusitis
• Muscle pain
• Hypoglycemia (especially with insulin/sulfonylureas)
• Anemia
• Bone fractures (especially in women)
• Macular edema
• Increased risk of heart failure
• Rarely, bladder cancer risk

Safety Measures

• Alcohol - Excessive alcohol consumption may increase the risk of hypoglycemia or fluid retention. Use with caution.
• Pregnancy - Not recommended during pregnancy due to potential fetal harm. Consult your doctor.
• Breastfeeding - It is unknown if pioglitazone is excreted in human milk. Not recommended during breastfeeding.
• Liver - Contraindicated in patients with active liver disease or elevated liver enzymes.
• Kidney - Generally safe for use in patients with kidney conditions, but monitor for fluid retention.
• Lung - Use with caution in patients with pre-existing lung conditions, especially those prone to fluid retention or heart failure.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.